Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF).

نویسندگان

  • A Angel-Moreno Maroto
  • E Martínez-Quintana
  • L Suárez-Castellano
  • J-L Pérez-Arellano
چکیده

1. Lischner M, Prokocimer M, Zolberg A, Shaklai M. Autoimmunity in chronic lymphocytic leukaemia. Postgrad Med J 1988;64:590–2. 2. Salvi A, Balestrier GP, Spandrio S, Franceschini R, Maroccolo M, Giustina G. Polymyositis associated with chronic lymphocytic leukemia. Clin Exp Rheumatol 1991;9:209–10. 3. Cherin P, Piette JC, Herson S, Raguin G, Godeau P. Polymyositis associated with chronic lymphocytic leukemia: a new case. Clin Exp Rheumatol 1992;10:423–4. 4. Heffner RR, Armbrustmacher VW, Earle KM. Focal myositis. Cancer 1977;40:301–6. 5. Flaisler F, Blin D, Asencio G, Lopez FM, Combe B. Focal myositis: a localized form of polymyositis? J Rheumatol 1993; 20:1414–6. 6. Naschitz JE, Yeshurun D, Dreyfuss U, Best LA, Misselevich I, Boss J. Localized nodular myositis. A paraneoplastic phenomenon. Clin Rheumatol 1992;11:427–31. 7. Harris GJ, Murphy ML, Schmidt EW, Hanson GA, Dotson RM. Orbital myositis as a paraneoplastic syndrome. Arch Ophthalmol 1994;112:380–6. 8. Bhatnagar D, Carey P, Pollard A. Focal myositis and elevated creatine kinase levels in a patient with phaeochromocytoma. Postgrad Med J 1986;62:197–8. 9. Pfinsgraff J, Buckingham RB, Killian PJ. Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum 1986;16:118–25. 10. Kunicka JE, Platsoucas CD. Defective helper function of purified T4 cells and excessive suppressor activity of purified T8 cells in patients with B-cell chronic lymphocytic leukemia. T4 suppressor effector cells are present in certain patients. Blood 1988;71:1551–60.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P-182: The Role of Vascular Endothelial Growth Factor Gene Expression in Patients with the History of Endometriosis

Background: Endometriosis is the presence of endometrium- like tissue in sites outside the uterine cavity, primarily on the pelvic peritoneum and ovaries. Ectopic endometrium for replacement and growth require to blood supply. Vascular endothelial growth factor (VEGF) is one of the most important intermediate of locality angiogenesis that product by monocytes and macrophages. This study evaluat...

متن کامل

Vascular endothelial growth factor and hypertrophic osteoarthropathy.

OBJECTIVE Hypertrophic osteoarthropathy (HOA) is characterized by the coexistence of digital clubbing and periosteal proliferation of the tubular bones. Localized vascular proliferation associated with platelet/endothelial cell activation are recognized features of this syndrome. Current knowledge suggests that HOA develops from the presence in the systemic circulation of one or more growth fac...

متن کامل

Pnm-9: Serum and Peritoneal Fluid Level of Vascular Endothelial Growth Factor in Endometriosis

Background: Endometriosis is known as one of the most common disease in women of reproductive age. Due to importance role of vascular endothelial growth factor (VEGF) in neo-vascularization for the implantation of endometrial cell and different reported results for VEGF level in the serum and peritoneal fluid (PF) in endometriosis patients, this study was designed to determine the serum and PF ...

متن کامل

Effect of different concentrations of leukemia inhibitory factor on gene expression of vascular endothelial growth factor-A in trophoblast Tumor Cell Line

Background: Several studies have shown that leukemia inhibitory factor (LIF) is one of the most important cytokinesparticipating in the process of embryo implantation and pregnancy, while, the role of this factor on vascular endothelialfactor-A (VEGF-A), as one of the most important angiogenic factor, has not been fully investigated yet. The aimof this study was to evaluate th...

متن کامل

Mesenchymal Stem Cells Differentiate to Endothelial Cells Using Recombinant Vascular Endothelial Growth Factor –A

Background: Vascular endothelial growth factor-A (VEGF-A), an endothelial cell-specific mitogen produced by various cell types, plays important roles in cell differentiation and proliferation. In this study we investigated the effect of recombinant VEGF-A on differentiation of mesenchymal stem cells (MSCs) to endothelial cells (ECs). Methods: VEGF-A was expressed in E. coli BL21 (DE3) and BL21...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Rheumatology

دوره 44 10  شماره 

صفحات  -

تاریخ انتشار 2005